Impact of Traditional Chinese Medicine on Breast Cancer Patients' Vital Energy
A Holistic Medical Approach - The Effect of "Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy" on Breast Cancer Patients Undergoing Cancer Therapy
This study is testing whether a Traditional Chinese Medicine program can help breast cancer patients feel better and improve their quality of life while they are receiving regular treatments.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | Taipei City Hospital Government |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Taipei) |
| Trial ID | NCT06337214 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effects of a Traditional Chinese Medicine (TCM) therapy program aimed at reinforcing vital energy in breast cancer patients undergoing conventional treatments. Participants will engage in TCM supportive therapy courses and receive educational and psychological support to enhance their quality of life. The study employs international standard questionnaires to assess the impact on patients' physical, emotional, spiritual, and social well-being. The goal is to determine if TCM can alleviate symptoms and improve overall satisfaction with cancer care.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 85 diagnosed with malignant breast tumors who are currently receiving cancer treatment.
Not a fit: Patients with benign tumors, those not undergoing conventional cancer treatments, or individuals with specific allergies to TCM may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the quality of life and symptom management for breast cancer patients undergoing conventional treatments.
How similar studies have performed: While the integration of TCM with conventional treatments is gaining interest, this specific approach is relatively novel and has not been extensively tested in similar studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals aged 18 years and above and below 85 years, willing to voluntarily participate in the study. * Diagnosed with malignant breast tumors, ICD-10: C50, by conventional medicine. * Patients currently undergoing cancer treatment, including chemotherapy, radiotherapy, or targeted therapy. Exclusion Criteria: * Diagnosed solely with carcinoma in situ or benign tumors, including fibrocystic breast conditions, by conventional medicine. * Patients regularly receiving Astragalus polysaccharide injections. * Patients with a history of allergies to Traditional Chinese Medicine. * Pregnant or breastfeeding women. * Individuals with a drug addiction habit, including both narcotic and non-narcotic drugs. * Any other situation where the participant is unable to cooperate (e.g., due to any factor that prevents participation, deemed unsuitable for participation by study staff, unwillingness to sign the consent form).
Where this trial is running
Taipei
- Taipei City Hospital — Taipei, Taiwan (Recruiting)
Study contacts
- Study coordinator: Yu-Hsuan Tai, MD
- Email: daidayangisele@gmail.com, DBB02@tpech.gov.tw
- Phone: +886918130891
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.